Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Rocket

3672.8000 58.20 (1.61%)

NSE Aug 14, 2026 15:31 PM

New 52W High today

Volume: 95,494

Ajanta Pharma Ltd.

29 Jul 2025

3672.80

1.61%

Ajanta Pharma (HOLD): Double-digit growth to continue; EBITDA margin constant

Hold: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Earnings were in line with our estimates with sales /EBITDA/PAT reported 1%/-2.7%/3% above estimates

Ajanta Pharma Ltd. has an average target of 3505.40 from 5 brokers.